AI Revolutionizes Cancer Gene Detection from Biopsy Images

Stanford Medicine researchers have developed an AI tool called SEQUOIA that can predict gene activity in tumor cells using standard biopsy images, potentially replacing costly and time-consuming genetic sequencing. This tool, which analyzes over 15,000 genes, could expedite clinical decision-making and reduce healthcare costs. SEQUOIA has shown high accuracy in predicting gene expression and patient outcomes, particularly in breast cancer, but requires further testing and FDA approval before clinical use.